Dose-response relationship — why more isn't always better
67 replies · Harm Reduction
I want to have a harm reduction discussion about dose escalation. A lot of people come into this community assuming that higher doses mean 'better' or 'deeper' experiences. I've seen people go from first-time 2g experiences to planning 5–7g heroic doses within a few months, chasing an experience that was profound at lower doses. Can we talk about why this progression can be risky and what the dose-response relationship actually looks like?
The dose-response is non-linear and highly context-dependent. Between 3.5g and 5g, you're not getting a proportionally deeper insight experience — you're getting overwhelm, ego dissolution that may or may not be therapeutic, and significantly higher probability of difficult experience requiring integration. Higher doses require proportionally more preparation, safer set and setting, and usually an experienced sitter. Most therapeutic research uses 25mg pure psilocybin (roughly 2.5–3.5g dried, strain-dependent) — not heroic doses.
There's also a tolerance ceiling effect: psilocybin produces tolerance rapidly. If you dose over 3g frequently, you'll need escalating doses to achieve the same subjective effect — which increases risk. The standard recommendation is 2+ weeks between sessions, and many integration-focused practitioners recommend 4–8 weeks for high-dose work.
From a harm reduction standpoint: the experiences people describe as 'too much' or traumatic almost always involve high doses in unprepared set/setting. The therapeutic window for most people is 2–3.5g in a well-prepared context. That's where the research is, and it's where the risk/benefit ratio is best.
64 more replies — forum posting coming soon.